COVID-19 diagnostic and control methodologies based on artificial intelligence
- Conditions
- Coronavirus infection of unspecified location
- Registration Number
- RBR-6gdmb8c
- Lead Sponsor
- Imunoscan Engenharia Molecular LTDA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Health professionals; emergency care patients; patients admitted to the infirmary; intensive care unit patients; symptomatic or asymptomatic for COVID-19.
Exclusion Criteria
Volunteers without contact with COVID-19 virus.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fast and effective diagnosis, enabling the hospital medical system to allocate infected patients permanently, and providing early treatment.
- Secondary Outcome Measures
Name Time Method Improvement of epidemiological data in the regions involved and reduction of hospitalizations.